What is Named Patient Purchase (NPP)?

A Named Patient Program (NPP) or sometime called as, Managed Access Program provides patients and respective clinician access to commercially approved medicines that are not available to them in their own country. These medicines must be approved in at least a single country, from which it can be imported into the patient’s territory/country under a Named Patient Program (NPP).

The innovator companies rarely plan to launch their drug/s in all the regions of the world. In such cases, clinician may be able to access much-needed medicines for rare disease, orphan disease, life-threatening, long-lasting, or seriously debilitating illness/disease from another country, to treat their specific patients, through a Named Patient Program (NPP).

The request must be unsolicited in all cases, and the following parameters must be met:

• The patient have a life-threatening, long-term, or severely debilitating condition. There are presently no approved medicines available for managing the disease or problem effectively. The patient is unable to participate in a continuing clinical experiment. The medicine/therapy must be in clinical testing or be in the application process for marketing authorization. Any Named Patient Program (NPP) requires that the product's benefit-risk profile be appraised as favourable for the eligible patients based on the most current available data, and that the intended use fall within the limitations of the product's unique indication.

• This programs enables treating physicians to make individual requests for specific patients under this Program.

• These could be medicine that have been approved but are not yet readily accessible for prescription in the patient's country. Approved and available in a single nation but cannot be available in the patient's own nation. In the patient's nation, but not in another. There is scarcity in the patient's nation but not in another.

• To obtain these life-saving medications, the government of India has created a provision allowing access to these medicines under the label of Named Patient Purchase (NPP). With previous approval from the Indian drug authority and customs department, these medicines can be obtained through medical distributors across the world.

Such requests for not yet authorised or not commercially accessible medicines can only be made by the treating physician of the specific patient.

If you are a doctor, patient, or relative of patient in need and you wish to buy such medicine through the Named Patient Program in India (NPP), please contact us today